InvestorsHub Logo
Followers 2
Posts 4653
Boards Moderated 0
Alias Born 12/25/2000

Re: None

Friday, 07/06/2007 7:29:31 AM

Friday, July 06, 2007 7:29:31 AM

Post# of 82595
Who will be part of M2Gen? Oct 24th Moffitt conference, I believe tells all....


http://www.moffitt.usf.edu/Site.aspx?spid=BEDDA8BDDDEA44B0AC1F5351B118DF02

(my guess)KEY PLAYERS IN M2Gen:::::::>(Using the October Conference)


Saffron Technology, Inc.
H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida
Ohio State University Comprehensive Cancer Center
Northwestern University
Roswell Park Cancer Institute
RedPath Integrated Pathology, Inc.
Merck Research Laboratories
Tony N. Frudakis, Ph.D.
DNA Print Genomics, Inc.
Ohio State University Comprehensive Cancer Center
Helicos BioSciences
University of Texas Southwestern Medical Center
Merck Research Laboratories
GE Healthcare
Hoosier Oncology Group
Johnson & Johnson Pharmaceutical Research & Development
Timothy Yeatman, M.D., F.A.C.S.
H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida















Manuel Arpacio, IV, Ph.D.

Saffron Technology, Inc.



Joffre Baker, Ph.D.

Genomic Health



Gerold Bepler, M.D., Ph.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



George Calin, M.D., Ph.D.

Ohio State University Comprehensive Cancer Center



David Cella, Ph.D.

Northwestern University



John Cowell, Ph.D., D.Sc., FCPath

Roswell Park Cancer Institute



William S. Dalton, Ph.D., M.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Sam Donaldson

ABC News



Steven A. Eschrich, Ph.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Martine Extermann, M.D., Ph.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Sydney Finkelstein, M.D.

RedPath Integrated Pathology, Inc.



Steven Friend, M.D., Ph.D.

Merck Research Laboratories



Tony N. Frudakis, Ph.D.

DNA Print Genomics, Inc.



Tyron Hoover, M.D., J.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Tim H-M Huang, Ph.D.

Ohio State University Comprehensive Cancer Center



Stanley Lapidus, BSEE

Helicos BioSciences



Johnathan Lancaster, M.D., Ph.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Richard Scheuermann, Ph.D.

University of Texas Southwestern Medical Center



Said Sebti, Ph.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Peter Shaw, Ph.D.

Merck Research Laboratories



Joseph V. Simone, M.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Dan Sullivan, M.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Javier Torres-Roca, M.D.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida



Jean-Luc Vanderheyden, Ph.D.

GE Healthcare



Jake Vinson, M.H.A.

Hoosier Oncology Group



Hong-Gang Wang, Ph.D.

H. Lee Moffitt Cancer Center & Research Institue at the University of South Florida



Hans Winkler, Ph.D.

Johnson & Johnson Pharmaceutical Research & Development



Timothy Yeatman, M.D., F.A.C.S.

H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida